Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

Stock Information for Ideanomics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Ideanomics Inc.

Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now
Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
Trinity Biotech to Present at Emerging Growth Conference
Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.